121 related articles for article (PubMed ID: 24249259)
21. The WTX Tumor Suppressor Interacts with the Transcriptional Corepressor TRIM28.
Kim WJ; Wittner BS; Amzallag A; Brannigan BW; Ting DT; Ramaswamy S; Maheswaran S; Haber DA
J Biol Chem; 2015 Jun; 290(23):14381-90. PubMed ID: 25882849
[TBL] [Abstract][Full Text] [Related]
22. Stat3 inhibits WTX expression through up-regulation of microRNA-370 in Wilms tumor.
Cao X; Liu D; Yan X; Zhang Y; Yuan L; Zhang T; Fu M; Zhou Y; Wang J
FEBS Lett; 2013 Mar; 587(6):639-44. PubMed ID: 23333300
[TBL] [Abstract][Full Text] [Related]
23. Germline mutations in WTX cause a sclerosing skeletal dysplasia but do not predispose to tumorigenesis.
Jenkins ZA; van Kogelenberg M; Morgan T; Jeffs A; Fukuzawa R; Pearl E; Thaller C; Hing AV; Porteous ME; Garcia-Miñaur S; Bohring A; Lacombe D; Stewart F; Fiskerstrand T; Bindoff L; Berland S; Adès LC; Tchan M; David A; Wilson LC; Hennekam RC; Donnai D; Mansour S; Cormier-Daire V; Robertson SP
Nat Genet; 2009 Jan; 41(1):95-100. PubMed ID: 19079258
[TBL] [Abstract][Full Text] [Related]
24. The tumor suppressor WTX shuttles to the nucleus and modulates WT1 activity.
Rivera MN; Kim WJ; Wells J; Stone A; Burger A; Coffman EJ; Zhang J; Haber DA
Proc Natl Acad Sci U S A; 2009 May; 106(20):8338-43. PubMed ID: 19416806
[TBL] [Abstract][Full Text] [Related]
25. Berberine inhibits Wilms' tumor cell progression through upregulation of Wilms' tumor gene on the X chromosome.
Liu Y; Liu S
Mol Med Rep; 2013 Nov; 8(5):1537-41. PubMed ID: 24002362
[TBL] [Abstract][Full Text] [Related]
26. Wilms tumor suppressor WTX negatively regulates WNT/beta-catenin signaling.
Major MB; Camp ND; Berndt JD; Yi X; Goldenberg SJ; Hubbert C; Biechele TL; Gingras AC; Zheng N; Maccoss MJ; Angers S; Moon RT
Science; 2007 May; 316(5827):1043-6. PubMed ID: 17510365
[TBL] [Abstract][Full Text] [Related]
27. Pathology, genetics and cytogenetics of Wilms' tumour.
Md Zin R; Murch A; Charles A
Pathology; 2011 Jun; 43(4):302-12. PubMed ID: 21516053
[TBL] [Abstract][Full Text] [Related]
28. The WTX tumor suppressor enhances p53 acetylation by CBP/p300.
Kim WJ; Rivera MN; Coffman EJ; Haber DA
Mol Cell; 2012 Mar; 45(5):587-97. PubMed ID: 22285752
[TBL] [Abstract][Full Text] [Related]
29. Comparative genomic hybridization analysis of hepatoblastomas: additional evidence for a genetic link with Wilms tumor and rhabdomyosarcoma.
Steenman M; Tomlinson G; Westerveld A; Mannens M
Cytogenet Cell Genet; 1999; 86(2):157-61. PubMed ID: 10545709
[TBL] [Abstract][Full Text] [Related]
30. [The tumor suppressor gene WTX, mutated in Wilms tumours, is a member of the beta-catenin destruction complex].
Angers S
Med Sci (Paris); 2007 Nov; 23(11):1025-7. PubMed ID: 18021721
[No Abstract] [Full Text] [Related]
31. Is WTX a suitable target for cancer therapy?
Perotti D; Radice P
Pediatr Blood Cancer; 2011 Apr; 56(4):682. PubMed ID: 21298763
[No Abstract] [Full Text] [Related]
32. PAX immunoreactivity identifies alveolar rhabdomyosarcoma.
Sullivan LM; Atkins KA; LeGallo RD
Am J Surg Pathol; 2009 May; 33(5):775-80. PubMed ID: 19145202
[TBL] [Abstract][Full Text] [Related]
33. The expression of WT1 in the differentiation of rhabdomyosarcoma from other pediatric small round blue cell tumors.
Carpentieri DF; Nichols K; Chou PM; Matthews M; Pawel B; Huff D
Mod Pathol; 2002 Oct; 15(10):1080-6. PubMed ID: 12379755
[TBL] [Abstract][Full Text] [Related]
34. Inactivation of the APC gene is constant in adrenocortical tumors from patients with familial adenomatous polyposis but not frequent in sporadic adrenocortical cancers.
Gaujoux S; Pinson S; Gimenez-Roqueplo AP; Amar L; Ragazzon B; Launay P; Meatchi T; Libé R; Bertagna X; Audebourg A; Zucman-Rossi J; Tissier F; Bertherat J
Clin Cancer Res; 2010 Nov; 16(21):5133-41. PubMed ID: 20978149
[TBL] [Abstract][Full Text] [Related]
35. Allelic loss but absence of mutations in the polyspecific transporter gene BWR1A on 11p15.5 in hepatoblastoma.
Albrecht S; Hartmann W; Houshdaran F; Koch A; Gärtner B; Prawitt D; Zabel BU; Russo P; Von Schweinitz D; Pietsch T
Int J Cancer; 2004 Sep; 111(4):627-32. PubMed ID: 15239143
[TBL] [Abstract][Full Text] [Related]
36. Wilms tumor genetics: a new, UnX-pected twist to the story.
Huff V
Cancer Cell; 2007 Feb; 11(2):105-7. PubMed ID: 17292822
[TBL] [Abstract][Full Text] [Related]
37. Detection of chimeric transcripts in desmoplastic small round cell tumor and related developmental tumors by reverse transcriptase polymerase chain reaction. A specific diagnostic assay.
de Alava E; Ladanyi M; Rosai J; Gerald WL
Am J Pathol; 1995 Dec; 147(6):1584-91. PubMed ID: 7495283
[TBL] [Abstract][Full Text] [Related]
38. Somatic mutations of the APC gene in sporadic hepatoblastomas.
Oda H; Imai Y; Nakatsuru Y; Hata J; Ishikawa T
Cancer Res; 1996 Jul; 56(14):3320-3. PubMed ID: 8764128
[TBL] [Abstract][Full Text] [Related]
39. Elevated expression of Wnt antagonists is a common event in hepatoblastomas.
Koch A; Waha A; Hartmann W; Hrychyk A; Schüller U; Waha A; Wharton KA; Fuchs SY; von Schweinitz D; Pietsch T
Clin Cancer Res; 2005 Jun; 11(12):4295-304. PubMed ID: 15958610
[TBL] [Abstract][Full Text] [Related]
40. Glypican-3 expression in Wilms tumor and hepatoblastoma.
Toretsky JA; Zitomersky NL; Eskenazi AE; Voigt RW; Strauch ED; Sun CC; Huber R; Meltzer SJ; Schlessinger D
J Pediatr Hematol Oncol; 2001 Nov; 23(8):496-9. PubMed ID: 11878776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
